{
    "success": true,
    "data": {
        "id": 1806128,
        "msgid": "who-and-brazil-urge-g7-to-finalise-global-pandemic-agreement-1781603451",
        "date": "2026-06-16 16:16:00",
        "title": "WHO and Brazil Urge G7 to Finalise Global Pandemic Agreement",
        "author": "Wisnu Arto Subari",
        "source": "MEDIA_INDONESIA",
        "tags": "",
        "topic": "Politics",
        "summary": "The World Health Organisation and Brazilian President Luiz In\u00e1cio Lula da Silva have jointly urged G7 leaders to break a deadlock over a crucial pathogen-sharing mechanism. The appeal, made during the G7 summit in France, stresses the urgent need to finalise the Pandemic Agreement's benefits-sharing annex to prepare for future outbreaks. The letter warns that delays leave the world vulnerable, citing a 25% chance of another pandemic within a decade.",
        "content": "<p>Amid the persistent threat of an Ebola epidemic, world leaders\ngathered at the G7 summit in France faced strong pressure to demonstrate\npolitical will. The push aims to finalise the outstanding section of the\nPandemic Agreement on Monday (15\/6). Through a joint letter, Brazilian\nPresident Luiz In\u00e1cio Lula da Silva and World Health Organisation (WHO)\nDirector-General Tedros Adhanom Ghebreyesus urged the leaders of the\nadvanced nations to sign the benefits-sharing annex with a sense of\nurgency. The Pandemic Agreement is designed to ensure the world is\nbetter prepared to face future global outbreaks. Although its broad\nframework was agreed upon last year, a vital element known as the\nPathogen Access and Benefit-Sharing (PABS) annex remains stalled due to\ndisputes over wording. The PABS system aims to establish a clear\nprotocol for sharing data on deadly pathogens. Currently, a similar\nsystem only exists for influenza viruses, whilst thousands of other\nlethal pathogens, including Ebola, lack a clear sharing protocol. Large\npharmaceutical companies fear the PABS scheme will force them to\nformally acknowledge the genetic resources of the country of origin,\nwhich they believe could disrupt intellectual property rights and limit\nprofits. Conversely, developing nations worry that if they provide\npathogen data free of charge, they will not gain access to resulting\nvaccines or medicines, as occurred during the COVID-19 pandemic. In the\nletter, Lula and Tedros cited 2023 research indicating a one-in-four\nchance of another pandemic occurring in the next decade. Factors such as\nclimate change, land-use changes, and agricultural evolution are said to\nbe altering the map of dangerous pathogen emergence. The letter stressed\nthat the belief that outbreaks only start in faraway places is no longer\ntrue, and future hotspots could emerge within or near one\u2019s own country.\nThe effort to reach a global deal faces significant challenges after the\nUnited States and Argentina withdrew from the WHO. The absence of the US\nis crucial given that the country is home to many of the world\u2019s largest\npharmaceutical companies. Nevertheless, an agreement among the remaining\n192 WHO member states is still considered a significant step forward.\nLula and Tedros concluded that every month the annex remains unfinished\nis a month the world becomes less prepared and people are less safe than\nthey should be. Finalising this agreement is seen not merely as a\nhumanitarian act, but as a collective promise to protect humanity from\nviral threats that know no borders.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/who-and-brazil-urge-g7-to-finalise-global-pandemic-agreement-1781603451",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}